RxDoctor Payments Data

Manoj Jagtiani, DO

Interventional Pain Medicine · Hays, KSNPI 1255829362

Payments from drug & device makers

What this record shows

16 manufacturers reported payments, led by Nalu Medical, Inc. at 26.4% of the total. Reporting peaked in 2024 at $4,205 and has fallen 61.7% since, to $1,609 in 2025.

$7,330in general payments, 2019–2025

Across 89 payments — averaging $82.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nalu Medical, Inc.$2K
  • Medtronic$2K
  • Nevro Corp.$1K
  • SPR Therapeutics, Inc$800
  • Stryker$583
  • Painteq LLC$270
  • plus $947 from 10 others

What the payments were for

  • Travel & lodging$2,96140%
  • Food & beverage$4,36960%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few interventional pain medicine providers in Kansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$297,810
Medicare patients
372
Services billed
14,349

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate24$17,097
Fentanyl28$7,871
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen254$7,628
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen131$4,577
Oxycodone Hcl134$3,390
Gabapentin149$2,502
Lidocaine17$1,919
Duloxetine Hcl44$1,405
Pregabalin19$1,069
Carisoprodol84$424
Tizanidine Hcl57$381
Morphine Sulfate ErMorphine Sulfate23$365
Methocarbamol18$348
Cyclobenzaprine Hcl22$153
Celecoxib15$132

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Hays

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →